Innovating Works

NANOGETIC

Activa
diaRNAgnosis: A novel platform for the direct profiling of circulating cell-free ribonucleic acids in biofluids DESTINA GENOMICA tramitó un H2020: Circulating cell-free ribonucleic acids (ccfRNAs) represent an emerging and important class of molecules, able to provide significant clinical relevance as novel screening, prognostic and therapy moni...
2021-01-01 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.